Page last updated: 2024-10-22

amitriptyline and Craniofacial Pain Syndromes

amitriptyline has been researched along with Craniofacial Pain Syndromes in 3 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gilden, DH1
Cohrs, RJ1
Hayward, AR1
Wellish, M1
Mahalingam, R1
Pearson, D1
Dalessio, DJ1

Other Studies

3 other studies available for amitriptyline and Craniofacial Pain Syndromes

ArticleYear
Chronic varicella-zoster virus ganglionitis--a possible cause of postherpetic neuralgia.
    Journal of neurovirology, 2003, Volume: 9, Issue:3

    Topics: 2-Aminopurine; Acyclovir; Amitriptyline; Analgesics, Non-Narcotic; Antibodies, Viral; Antiviral Agen

2003
Facial pain.
    British medical journal, 1970, Jan-03, Volume: 1, Issue:5687

    Topics: Amitriptyline; Facial Neuralgia; Herpesviridae Infections; Humans; Leukemia, Lymphoid; Neurofibromat

1970
Some reflections on the etiologic role of depression in head pain.
    Headache, 1968, Volume: 8, Issue:1

    Topics: Amitriptyline; Antidepressive Agents; Chronic Disease; Depression; Facial Neuralgia; Headache; Human

1968